AMIKACIN SULFATE INJECTION
Google image searchProduct monograph
Active ingredient
amikacin (amikacin sulfate), 250 MG/ML
DIN: 02525909
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR, INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Prescription
Company: HIKMA CANADA LIMITED
Date: 28-APR-2023
ATC:
- J01 — ANTIBACTERIALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J01G — AMINOGLYCOSIDE ANTIBACTERIALS (ATC, ATC/DDD)
- J01GB — Other aminoglycosides (ATC, ATC/DDD)
- J01GB06 — AMIKACIN (ATC/DDD)
Reference brand drug: Amikin
Pharmaceutical standard: MFR
